Aclarion (ACONW) Competitors $0.03 0.00 (-2.65%) As of 05/2/2025 01:57 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock ACONW vs. AONC, DHACW, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, NTRA, FMS, and HIMSShould you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), Fresenius Medical Care (FMS), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. Aclarion vs. American Oncology Network Digital Health Acquisition LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute Natera Fresenius Medical Care Hims & Hers Health Aclarion (NASDAQ:ACONW) and American Oncology Network (NASDAQ:AONC) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, community ranking, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings. Does the media prefer ACONW or AONC? In the previous week, Aclarion's average media sentiment score of 1.87 beat American Oncology Network's score of -1.32 indicating that Aclarion is being referred to more favorably in the media. Company Overall Sentiment Aclarion Very Positive American Oncology Network Negative Is ACONW or AONC more profitable? Company Net Margins Return on Equity Return on Assets AclarionN/A N/A N/A American Oncology Network N/A N/A N/A Which has higher valuation and earnings, ACONW or AONC? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$45.72KN/AN/AN/AN/AAmerican Oncology Network$1.34BN/AN/AN/AN/A Does the MarketBeat Community believe in ACONW or AONC? Aclarion and American Oncology Network both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAclarionN/AN/AAmerican Oncology NetworkN/AN/A SummaryAclarion and American Oncology Network tied by winning 1 of the 2 factors compared between the two stocks. Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACONW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACONW vs. The Competition Export to ExcelMetricAclarionHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$209.78M$5.56B$8.04BDividend YieldN/A6.68%5.09%4.22%P/E RatioN/A220.1322.6818.83Price / SalesN/A427.57404.28106.72Price / CashN/A47.1438.1834.62Price / BookN/A5.346.794.33Net IncomeN/A-$15.55M$3.22B$247.97M7 Day PerformanceN/A-0.21%3.36%3.18%1 Month PerformanceN/A1.49%6.94%8.13%1 Year PerformanceN/A5.30%16.11%5.01% Aclarion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACONWAclarionN/A$0.03-2.7%N/A-7.3%$0.00$45,724.000.007Positive NewsGap DownAONCAmerican Oncology NetworkN/A$6.30-2.3%N/A+72.0%$0.00$1.34B0.001,520News CoveragePositive NewsDHACWDigital Health AcquisitionN/A$0.04flatN/AN/A$0.00N/A0.00N/ALFMDPLifeMDN/A$23.93+3.7%N/A+6.9%$0.00$212.45M0.00230Upcoming EarningsGap UpOTRKPOntrakN/A$0.23+0.0%N/AN/A$0.00$10.84M0.00250Gap DownPIIIWP3 Health PartnersN/A$0.01-4.7%N/A-84.7%$0.00$1.50B0.00500Gap UpHigh Trading VolumeTALKWTalkspaceN/A$0.12+6.5%N/A-47.1%$0.00$187.59M0.00500Positive NewsTOIIWOncology InstituteN/A$0.08-15.4%N/A-63.5%$0.00$393.41M0.00660Short Interest ↓NTRANatera2.8996 of 5 stars$154.89+1.2%$175.76+13.5%+67.2%$20.94B$1.70B-88.013,020Upcoming EarningsInsider TradePositive NewsFMSFresenius Medical Care3.8487 of 5 stars$24.98-0.4%$25.30+1.3%+18.3%$14.66B$19.34B20.64123,200Upcoming EarningsPositive NewsGap UpHIMSHims & Hers Health2.4139 of 5 stars$35.08+23.2%$36.92+5.2%+234.5%$7.79B$1.48B79.73650Upcoming EarningsAnalyst ForecastInsider TradeOptions VolumeNews CoverageHigh Trading Volume Related Companies and Tools Related Companies AONC Alternatives DHACW Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives NTRA Alternatives FMS Alternatives HIMS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACONW) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredMassive red flag about American consumerWhy is the U.S. Dollar suddenly crashing? Pundits on either side of the aisle have been warning that the U....Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACONW Stock Free ACONW Stock Alerts